▲ Peaking
Business
Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Itm
2 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Itm
This hub groups 2 separate news trends connected to Itm, spanning August 10, 2026 through September 21, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 11 article observations and 11 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 fades ✓
In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment
The FDA's rejection of ITM's radiopharma therapy sends shockwaves through the pharmaceutical industry.